Eaton Vance Management’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$384K Hold
23,062
﹤0.01% 1386
2022
Q2
$339K Hold
23,062
﹤0.01% 1444
2022
Q1
$572K Hold
23,062
﹤0.01% 1491
2021
Q4
$740K Sell
23,062
-186,189
-89% -$6.8M ﹤0.01% 1239
2021
Q3
$7.53M Buy
209,251
+91,127
+77% +$3.59M 0.01% 623
2021
Q2
$5.21M Buy
118,124
+49,983
+73% +$2.18M 0.01% 776
2021
Q1
$3.12M Sell
68,141
-31,859
-32% -$1.83M ﹤0.01% 874
2020
Q4
$6.9M Buy
+100,000
New +$4.9M 0.01% 623

Other funds holding LUNG

Eaton Vance Management's LUNG Position: Q3 2022 in Review

Eaton Vance Management held its Pulmonx (LUNG) position steady in Q3 2022 at 23,062 shares worth $384K. The position accounts for ﹤0.01% of the portfolio, ranked #1386.

Eaton Vance Management first reported a position in LUNG in Q4 2020 and has held it in 8 quarters since. The position peaked at $7.53M in Q3 2021. 104 funds tracked by Wall St. Rank hold LUNG as of Q3 2022.

  • Eaton Vance Management held 23,062 shares of Pulmonx worth $384K as of Q3 2022.
  • Eaton Vance Management left its Pulmonx share count unchanged in Q3 2022.
  • Pulmonx made up ﹤0.01% of Eaton Vance Management's portfolio in Q3 2022, its #1386 holding.
  • Eaton Vance Management first reported a position in Pulmonx in Q4 2020 and has held it in 8 quarters since.
  • Eaton Vance Management's Pulmonx position peaked at $7.53M in Q3 2021.
  • 104 funds tracked by Wall St. Rank held Pulmonx as of Q3 2022.

Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.